Novo Nordisk, a Danish pharmaceutical company, announced yesterday that a late-stage trial demonstrated the efficacy of a high-dose oral version of its drug semaglutide in assisting overweight or obese adults in losing 15% of their body weight. This outcome aligns with recent findings from other experimental obesity pills. Novo Nordisk intends to pursue regulatory approval for the high-dose pill...
Tag: <span>anti-obesity pill</span>
Post
An anti-obesity pill that turns off hunger could be on the horizon
by Study Finds REHOVOT, Israel — For people battling obesity, it’s one thing to lose weight, but how do you stop feeling hungry? A new study is revealing how a unique “switch” in the brain controls when people feel full. Researchers say the findings may soon lead to an anti-obesity pill that turns off hunger. Scientists from the...